WallStreetZen

NASDAQ: NVCN
Neovasc Inc Stock Forecast, Predictions & Price Target

Analyst price target for NVCN

Based on 1 analysts offering 12 month price targets for Neovasc Inc.
Min Forecast
$2.00+172.11%
Avg Forecast
$2.00+172.11%
Max Forecast
$2.00+172.11%

Should I buy or sell NVCN stock?

Based on 1 analysts offering ratings for Neovasc Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

NVCN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
SVB Leerink
BuyMaintains$2.00+172.11%2020-11-06

1 of 1

Forecast return on equity

Is NVCN forecast to generate an efficient return?
Company
-1,433.63%
Industry
28%
Market
2,530.69%
NVCN's Return on Equity is forecast to be low in 3 years (-1,433.63%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is NVCN forecast to generate an efficient return on assets?
Company
-158.57%
Industry
14.57%
Market
1,237.47%
NVCN is forecast to generate lower Return on Assets (-158.57%) than the US Medical Devices industry average (14.57%)
Forecast

NVCN earnings per share forecast

What is NVCN's earnings per share in the next 3 years based on estimates from 1 analysts?
Avg 1 year Forecast
-$0.36-79.07%
Avg 2 year Forecast
-$0.08-95.35%
Avg 3 year Forecast
-$0.89-48.26%

NVCN revenue forecast

What is NVCN's revenue in the next 3 years based on estimates from 1 analysts?
Avg 1 year Forecast
$4.8M+145.23%
Avg 2 year Forecast
$30.5M+1,458.22%
Avg 3 year Forecast
$3.0M+53.27%
NVCN's revenue is forecast to grow at an exceptional rate of 82.34% per year
Forecast

NVCN revenue growth forecast

How is NVCN forecast to perform vs Medical Devices companies and vs the US market?
Company
82.34%
Industry
7.53%
Market
12.38%
NVCN's revenues are forecast to grow faster (82.34% per year) than the US Medical Devices industry average (7.53%)
Forecast
NVCN's revenues are forecast to grow faster (82.34% per year) than the US market average (12.38%)
Forecast

Neovasc Stock Forecast FAQ

Is Neovasc Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 1 Wall Street analysts covering (NASDAQ: NVCN) stock is to Buy NVCN stock.

Out of 1 analysts, 0 (0%) are recommending NVCN as a Strong Buy, 1 (100%) are recommending NVCN as a Buy, 0 (0%) are recommending NVCN as a Hold, 0 (0%) are recommending NVCN as a Sell, and 0 (0%) are recommending NVCN as a Strong Sell.

What is NVCN's earnings growth forecast for 2021-2023?

(NASDAQ: NVCN) Neovasc's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 25.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.62%.

Neovasc's earnings in 2021 is -$28,695,041.On average, 1 Wall Street analysts forecast NVCN's earnings for 2021 to be $-10,414,410, with the lowest NVCN earnings forecast at $-10,414,410, and the highest NVCN earnings forecast at $-10,414,410. On average, 1 Wall Street analysts forecast NVCN's earnings for 2022 to be $-2,314,313, with the lowest NVCN earnings forecast at $-2,314,313, and the highest NVCN earnings forecast at $-2,314,313.

In 2023, NVCN is forecast to generate $-25,746,735 in earnings, with the lowest earnings forecast at $-25,746,735 and the highest earnings forecast at $-25,746,735.

What is NVCN's revenue growth forecast for 2021-2023?

(NASDAQ: NVCN) Neovasc's forecast annual revenue growth rate of 82.34% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.53%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 12.38%.

Neovasc's revenue in 2021 is $1,957,362.On average, 1 Wall Street analysts forecast NVCN's revenue for 2021 to be $138,858,797, with the lowest NVCN revenue forecast at $138,858,797, and the highest NVCN revenue forecast at $138,858,797. On average, 1 Wall Street analysts forecast NVCN's revenue for 2022 to be $882,331,938, with the lowest NVCN revenue forecast at $882,331,938, and the highest NVCN revenue forecast at $882,331,938.

In 2023, NVCN is forecast to generate $86,786,748 in revenue, with the lowest revenue forecast at $86,786,748 and the highest revenue forecast at $86,786,748.

What is NVCN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: NVCN) forecast ROA is -158.57%, which is lower than the forecast US Medical Devices industry average of 14.57%.

What is NVCN's Price Target?

According to 1 Wall Street analysts that have issued a 1 year NVCN price target, the average NVCN price target is $2.00, with the highest NVCN stock price forecast at $2.00 and the lowest NVCN stock price forecast at $2.00.

On average, Wall Street analysts predict that Neovasc's share price could stay at $2.00 by Nov 6, 2021. The average Neovasc stock price prediction forecasts a potential downside of N/A from the current NVCN share price of $0.74.

What is NVCN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: NVCN) Neovasc's current Earnings Per Share (EPS) is -$1.72. On average, analysts forecast that NVCN's EPS will be $-0.36 for 2021, with the lowest EPS forecast at $-0.36, and the highest EPS forecast at $-0.36. On average, analysts forecast that NVCN's EPS will be $-0.08 for 2022, with the lowest EPS forecast at $-0.08, and the highest EPS forecast at $-0.08. In 2023, NVCN's EPS is forecast to hit $-0.89 (min: $-0.89, max: $-0.89).

What is NVCN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: NVCN) forecast ROE is -1,433.63%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.